Literature DB >> 27350671

Beneficial role of D allele in controlling ACE levels: a study among Brahmins of north India.

Shobha Kumari1, Nidhi Sharma, Sunil Thakur, Prakash R Mondal, Kallur N Saraswathy.   

Abstract

India being a country with vast diversity is expected to have different dietary and life style patterns which in turn may lead to population-specific environmental risk factors. Further, the interaction of these risk factors with the genetic makeup of population makes it either susceptible or resistant to cardiovascular disease. One such candidate gene is angiotensin converting enzyme (ACE) for various cardiovascular mechanisms. ACE is the key enzyme of the renin angiotensin aldosterone system pathway which maintains homeostasis blood pressure in the body and any variation in the levels is reported to be associated with various complex diseases. The DD genotype is found to increase ACE levels, which is associated with cardiovascular diseases and decrease in ACE levels are associated with kidney diseases. The aim of this study was to understand the distribution of ACE I/D polymorphism and ACE levels among Brahmins of National Capital Region (NCR) north India, with respect to age and sex ratio distribution. In this study, 136 subjects of which 50 males and 86 females, who were unrelated up to first cousin, aged 25 to70 years were studied. ACE gene was found to be polymorphic with high frequency of heterozygote (ID) followed by II and DD genotypes. The studied population was found to be in Hardy-Weinberg equilibrium with respect to ACE I/D polymorphism (P = 0.55). I allele frequency was found to be higher (0.560) than the D allele (0.44). The median level of ACE was found to be 65.96 ng/mL (48.12-86.24) which is towards lower side of the normal range. ACE levels were found to be increased among individual having either of the homozygotes that is II or DD and higher frequency of heterozygote (ID) is indicative of advantage in the population by maintaining lower ACE levels. The limitation of the present study is low sample size, however, the merit is that the subjects belonged to a Mendalian population with a common gene pool.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27350671     DOI: 10.1007/s12041-016-0649-7

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  10 in total

1.  Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins.

Authors:  M A Qadar Pasha; Amjad P Khan; Ratan Kumar; Rekh B Ram; Surinder K Grover; Kaushal K Srivastava; William Selvamurthy; Samir K Brahmachari
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Effect of angiotensin converting enzyme gene I/D polymorphism in patients with metabolic syndrome in North Indian population.

Authors:  Gaurav Mittal; Vibhanshu Gupta; Shahzad F Haque; Anwer S Khan
Journal:  Chin Med J (Engl)       Date:  2011-01       Impact factor: 2.628

4.  Angiotensin-converting enzyme insertion/deletion gene polymorphism in general population of west Azarbaijan, Iran.

Authors:  Isa Abdi Rad; Morteza Bagheri
Journal:  Iran J Kidney Dis       Date:  2011-03       Impact factor: 0.892

Review 5.  ACE polymorphisms.

Authors:  F A Sayed-Tabatabaei; B A Oostra; A Isaacs; C M van Duijn; J C M Witteman
Journal:  Circ Res       Date:  2006-05-12       Impact factor: 17.367

6.  Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism, plasma angiotensin converting enzyme activity, and left ventricular mass in a normotensive Chilean population.

Authors:  J E Jalil; A M Piddo; S Cordova; G Chamorro; S Braun; R Jalil; J Vega; L Jadue'P; S Lavandero; P Lastra
Journal:  Am J Hypertens       Date:  1999-07       Impact factor: 2.689

7.  Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.

Authors:  F Cambien; O Costerousse; L Tiret; O Poirier; L Lecerf; M F Gonzales; A Evans; D Arveiler; J P Cambou; G Luc
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

8.  Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population.

Authors:  Ipsita Choudhury; R Jothimalar; Arun Kumar Patra
Journal:  Indian J Clin Biochem       Date:  2012-05-05

9.  Hypertension subtypes and angiotensin converting enzyme (ACE) gene polymorphism in Indian population.

Authors:  P K Borah; P Shankarishan; N C Hazarika; J Mahanta
Journal:  J Assoc Physicians India       Date:  2012-06

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

  10 in total
  2 in total

1.  Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients.

Authors:  Neerja Aggarwal; Pawan Kumar Kare; Parul Varshney; Om Prakash Kalra; Sri Venkata Madhu; Basu Dev Banerjee; Anil Yadav; Alpana Raizada; Ashok Kumar Tripathi
Journal:  World J Diabetes       Date:  2017-03-15

2.  Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism.

Authors:  Abdulrahman Hamdan Almaeen; Gomaa Mostafa-Hedeab
Journal:  Pharmgenomics Pers Med       Date:  2021-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.